As shown in Figures 8(h)–8(l), increased DLGAP5 expression was significantly correlated with pathologic stage (stage III vs. stage I, P = 0.02), T stage (T2 vs. T1, P < 0.001), N stage (N2 vs. N0, P = 0.03), tumor status (with tumor vs. tumor free, P < 0.001), and primary therapy outcome (PD vs. CR, P < 0.001). The gene discussed is DLGAP5; the disease is neoplasm.